Santegoets, Saskia J A M <br/><br/>
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Dec 2006 
 - 1480-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/s00262-006-0142-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--immunology<br/>Antigens, Neoplasm--immunology<br/>Carcinoembryonic Antigen--immunology<br/>Cell Line, Tumor<br/>Clone Cells<br/>Dendritic Cells--immunology<br/>HLA-A2 Antigen--metabolism<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Neoplasms--therapy<br/>RNA-Binding Proteins<br/>Receptor, ErbB-2--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Telomerase--immunology